Insights provides context and perspective about key pharmacy trends and issues

Cost Management
New CMS rule enables Medicare Part B Payors to use step therapy to direct patients to lower-cost, clinically appropriate medications first, giving them an opportunity to implement... More
Briefing
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set launch... More
Commentary
Cost Management
CVS Health has one of the most comprehensive solutions in the market today, which has proven to save members $120-$130 per fill by making actionable, up-to-the-minute, member-specific... More
Feature
Cost Management
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker profits. More
White Paper
Cost Management
Up to 30 percent of ER visits could potentially be treated in walk-in clinics like MinuteClinic. Payors may reduce unnecessary ER visits by increasing member awareness of MinuteClinic. More
Briefing
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the government can do... More
Commentary
Cost Management
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set drug prices. More
Commentary
Cost Management
Managed formulary strategies helped CVS Health clients contain drug price growth, lower trend and improve adherence in 2017. More
Video
Cost Management
Our formulary strategies effectively leverage competition in the pharmaceutical market to help reduce costs and trend for PBM clients. More
Video
Cost Management
Jon Roberts highlights how pharmacy benefit management strategies helped keep unit cost growth to just 0.2 percent despite near 10 percent rate of drug price inflation. More
Video